Generic Supply Chain

AAM Releases Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

WASHINGTON, DC (April 30, 2020) — The Association for Accessible Medicines today released “A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain,” a six-element framework that lays out concrete actions that the federal government could take to ensure that U.S. patients and the U.S. health care system have access to a secure and consistent supply of critical pharmaceuticals.

COVID-19 Response: Anthony Maffia at Sandoz

Anthony Maffia works in New Jersey at Sandoz as Vice President, Head of Regulatory Affairs, North America.

AAM is recognizing dedicated people like Anthony and his peers across the generic & biosimilar industry who show up each day for US patients.

The industry is "finding new and creative and rapid ways to get medication into the hands of patients that need it.”

COVID-19 Response: Roby Epting at Sandoz

Roby Epting is a manager of second-shift operations at Sandoz in Wilson, North Carolina.

AAM is recognizing dedicated people like Roby and his peers across the generics and biosimilars industry who show up each day for U.S. patients.

"We are just excited to be able to contribute in any kind of way."

Learn more at: https://accessiblemeds.org/COVID-19-FAQs

Generic and Biosimilar Competition Is Cornerstone of President Trump’s Blueprint to Lower Drug Prices for American Patients

Administration’s Plan Embraces Getting More Generic and Biosimilar Medicines to Patients

WASHINGTON DC (May 11, 2018) – In President Trump’s remarks today at the White House, he made clear the essential role that generic and biosimilar medicines play in containing prescription drug costs for patients.

Subscribe to Generic Supply Chain

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.